Dr Alison Tree’s team develops new precise radiotherapy techniques using simulations and real patient data, as well as with innovative clinical trials.
Dr Alison Tree is a clinical researcher investigating the benefits of profoundly hypofractionated radiotherapy in urological cancers. She is involved in several national and international trials of innovative radiotherapy strategies, and has a particular interest in prostate cancer.